Rainer Blair to retire WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) announced that the Company’s Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a member of the Board of Directors, effective October 1, 2026. On that date, Rainer Blair will retire and serve as a […]
TORRANCE, CA, – Phenomenex Inc., a Danaher company and global leader in advanced technologies for the separation sciences, today announced the appointment of Dr. Lauryn Bailey as President of Phenomenex. Dr. Bailey joined Phenomenex in 2022 and has played an important role in advancing the company’s commercial and strategic priorities. “I’m honored to lead Phenomenex and […]
Jena, Germany | ZEISS Photonics & Optics Effective November 1, 2026, there will be a leadership change at ZEISS Spectroscopy. After eight years at the helm of Carl Zeiss Spectroscopy GmbH, Dr. Christian Korth will pursue his career outside ZEISS at LINHARDT Group. Dr. Daniel Beck, currently Head of Strategy at ZEISS Photonics & Optics, […]
Backed by KKR’s £4.7 billion acquisition of Malvern Panalytical parent company Spectris, the materials characterization leader enters a new era of innovation, customer focus, and long-term ambition. Malvern, UK, Sciad Communications — Malvern Panalytical is setting an ambitious new course for growth, with Christian Sauber, Ph.D., as President and following the acquisition of its parent company Spectris […]
Dan Malarek, current CEO of Foundation Medicine Inc., appointed President and CEO of Roche Diagnostics North America, effective August 1, 2026 Malarek succeeds Brad Moore, who will retire at the end of July following nearly a decade of distinguished service at Roche Antonio Vergara appointed Chief Commercial Officer to lead U.S. commercial business units INDIANAPOLIS […]
Adam Brown has been appointed Managing Director, assuming responsibility for the day-to-day leadership of the business As part of the transition, Richard Brown will become Chairman after 26 years as Managing Director, while John Clapham will continue supporting the company in his role as Founder. The changes reflect a planned succession process that combines continuity, […]
Luba Greenwood joins Cytosurge’s Board of Directors to support the company’s next phase of commercial growth and scientific progress as Cytosurge builds the causal data foundation for AI-driven drug discovery. ZURICH, Switzerland – Cytosurge, the pioneer of Same-Cell Biology, announces the election of Luba Greenwood, J.D., to its Board of Directors, effective July 9, 2026. Greenwood is a […]
Applied AI and life sciences leader joins L7’s executive team to advance the L7|SYNAPSE™ Agentic AI strategy across the customer base AUSTIN, Texas — L7 Informatics, Inc., the company behind L7|ESP®, the Enterprise Science Platform that serves as an operating system for precision science, today named Ray Veeraraghavan, Ph.D., Vice President of Science and AI. […]
Peabody, Mass. — JEOL USA, Inc. has expanded its Board of Directors with the appointment of two members of its leadership team, Donna Gosselin and Steve Tryon. In addition, Dr. Thomas Isabell was appointed President of JEOL USA. Together, they bring decades of leadership experience spanning product management, applications, and field service, further strengthening the company’s […]
San Francisco, California – Yavne, Israel – Genopore, the next-generation proteomics company developing the first semiconductor based optical nanopore technology platform with AI/ML analysis for direct single protein molecule identification and digital quantification, today announced the appointment of life science leader Rey Mali as its new Chief Executive Officer, with immediate effect. Rey Mali brings more […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
